CLPT.NASDAQClearpoint Neuro, INC
Form 4: ClearPoint Neuro CEO Joseph Burnett Reports Stock Transactions
Sentiment:
SEC Form 4 Filing
ClearPoint Neuro CEO Joseph Michael Burnett reports the acquisition and disposal of common stock and restricted stock units.
Summary
- On March 12, 2025, Joseph Michael Burnett, CEO and President of ClearPoint Neuro, Inc., engaged in transactions involving the company's stock.
- Burnett acquired 42,414 shares of common stock through the settlement of restricted stock units.
- He also disposed of 23,405 shares to cover tax withholding obligations at a price of $13.18 per share.
- Following these transactions, Burnett directly owns 290,132 shares of ClearPoint Neuro common stock.
- He also owns 169,657 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reporting stock transactions by an officer. It doesn't inherently convey positive or negative sentiment.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in the CEO's holdings.
Key Dates
| Date | Description |
|---|---|
| 03/12/2025 | Date of stock transactions: acquisition of shares via restricted stock unit settlement and disposal of shares for tax obligations. |
| 03/14/2025 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.